Tivozanib Promising for Metastatic Renal Cell Carcinoma
Tivozanib (AV-951) was well tolerated and improved median progression-free survival (PFS) in some patients with advanced renal cell carcinoma (RCC), according to the results of a phase II study...
View ArticlePartial Nephrectomy is Associated with Improved Survival in Early Stage...
Patients with early stage kidney cancer who had only the tumor removed experienced better survival rates than those who had the entire kidney removed, according to the results of a study published in...
View ArticleApproximately 16% of Worldwide Cancers Caused By Preventable Infections
Two million cancer cases each year—or roughly 16 percent of cancers worldwide—are the result of preventable and treatable infections such as human papillomavirus (HPV) and Hepatitis C (HCV), according...
View ArticleCoping with Taste Changes
If you’re undergoing chemotherapy, biologic therapy, or radiation to the head or neck area, one of the side effects you may experience is a change in how things taste. While this may seem like a minor...
View ArticlePD-1 Targeted Immune Therapy Shows Promising Activity
The investigational drug BMS-936558 caused tumor shrinkage in nearly 25 percent of patients with advanced melanoma, kidney cancer and non-small cell lung cancer (NSCLC), according to the results of a...
View ArticleMen, Fertility, and Cancer
Men who confront a cancer diagnosis before beginning or completing their families may have many questions about how cancer treatment will affect their ability to have children in the future. The good...
View ArticleWomen, Fertility and Cancer
Women who confront a cancer diagnosis before beginning or completing their families may have many questions about how cancer treatment will affect their ability to have children in the future. The good...
View ArticleCaregivers
What is Caregiving and Who are Caregivers? Caregivers are individuals who provide care to chronically ill or disabled family members or friends. It is estimated that more than one quarter of the adult...
View ArticleAdvanced Directives
Living Wills Every competent adult has, in most cases, the freedom to accept or refuse medical treatment. When you are well, you can talk with your physician and family and make your wishes known....
View ArticleNew Treatment Options for Advanced Renal Cell Carcinoma
The results from three phase III trials shed new light on treatment options for patients with advanced renal cell carcinoma. The studies were presented at the ESMO 2012 Congress of the European Society...
View ArticleCancer Deaths on the Decline
Overall cancer death rates continue to decline in both men and women and across major ethnic and racial groups, according to the annual Status of Cancer report published in the Journal of the National...
View ArticleFollowing Lifestyle Recommendations Reduces Risk of Cancer Death
People who follow the diet and lifestyle recommendations laid out by the World Cancer Research Fund (WCRF) and the American Institute for Cancer Research (AICR) have a 34 percent reduced risk of dying...
View ArticleUnderstanding Osteonecrosis of the Jaw
Cancer and its treatment can come with a variety of complications, some more serious than others. What Is Osteonecrosis of the Jaw? Osteonecrosis of the jaw (ONJ) is a severe bone disease that occurs...
View ArticleEnd-of-Life Care Remains Aggressive, Despite Patient Wishes
Although most patients with advanced cancer prefer hospice or palliative care that minimizes symptoms, many continue to receive aggressive treatment during their final weeks and months of life. In...
View ArticlePD-1 Targeted Immune Therapy Shows Promising Activity
The investigational drug BMS-936558 caused tumor shrinkage in nearly 25 percent of patients with advanced melanoma, kidney cancer and non-small cell lung cancer (NSCLC), according to the results of a...
View ArticleClik here to view.
Strategies to Improve Treatment
STRATEGIES TO IMPROVE TREATMENT The development of more effective cancer treatments requires that new and innovative therapies be evaluated with cancer patients. Clinical trials are studies that...
View ArticleFirst-Line Inlyta Active in Metastatic Kidney Cancer
First-line therapy with Inlyta® (axitinib) demonstrated clinical activity in metastatic renal cell carcinoma, according to the results of a study published in The Lancet Oncology. Each year in the...
View ArticleClik here to view.
Strategies to Improve Treatment
The development of more effective cancer treatments requires that new and innovative therapies be evaluated with cancer patients. Clinical trials are studies that evaluate the effectiveness of new...
View ArticleMarriage May Have a Protective Effect for Cancer Patients
Social support may have a significant impact on cancer detection, treatment, and survival, according to the results of a study published in the Journal of Clinical Oncology. The study showed that...
View Article
